BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1137 related articles for article (PubMed ID: 15212657)

  • 1. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation.
    Kim ES; Kim TY; Koh JM; Kim YI; Hong SJ; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):145-8. PubMed ID: 15212657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thyroid cancer--the malignant lesions in the contralateral lobe].
    Vărcuş F; Bordoş D; Cornianu M; Nicolicea A; Coman A; Lazăr F
    Chirurgia (Bucur); 2011; 106(6):765-8. PubMed ID: 22308914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
    Koo BS; Lim HS; Lim YC; Yoon YH; Kim YM; Park YH; Rha KS
    Ann Surg Oncol; 2010 Apr; 17(4):1101-5. PubMed ID: 20066517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
    Grigsby PW; Reddy RM; Moley JF; Hall BL
    Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
    Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
    Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma.
    Scheumann GF; Seeliger H; Musholt TJ; Gimm O; Wegener G; Dralle H; Hundeshagen H; Pichlmayr R
    Eur J Surg; 1996 Sep; 162(9):677-84. PubMed ID: 8908447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of completion thyroidectomy following unilateral lobectomy for well-differentiated thyroid cancer.
    Kupferman ME; Mandel SJ; DiDonato L; Wolf P; Weber RS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1209-12. PubMed ID: 12169901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necessity and safety of completion thyroidectomy for differentiated thyroid carcinoma.
    De Jong SA; Demeter JG; Lawrence AM; Paloyan E
    Surgery; 1992 Oct; 112(4):734-7; discussion 737-9. PubMed ID: 1411945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical treatment and long-term efficacy on stage T1-3N0 differentiated thyroid carcinoma].
    Li QL; Chen FJ; Zeng ZY; Guo ZM; Song M; Yang AK
    Ai Zheng; 2008 Mar; 27(3):299-303. PubMed ID: 18334121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
    Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S
    World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocality of thyroid carcinomas: a "privilege" of papillary tumors or not?
    Papageorgiou MS; Liratzopoulos N; Efremidou EI; Karanikas M; Minipoulos G; Manolas KJ
    G Chir; 2010; 31(1-2):20-3. PubMed ID: 20298661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical recurrence of papillary thyroid cancer in the remnant lobe.
    Asanuma K; Kobayashi S; Sugenoya A; Yokoyama S; Shingu K; Hama Y; Itoh N; Kasuga Y; Amano J
    Eur J Surg; 2000 Mar; 166(3):202-6. PubMed ID: 10755332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Small thyroid carcinomas: biological characteristics, diagnosis and therapy].
    Gemsenjäger E; Schweizer I
    Schweiz Med Wochenschr; 1999 May; 129(18):681-90. PubMed ID: 10407941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary carcinoma of the thyroid: can operative management be based solely on fine-needle aspiration?
    Chen H; Zeiger MA; Clark DP; Westra WH; Udelsman R
    J Am Coll Surg; 1997 Jun; 184(6):605-10. PubMed ID: 9179117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical treatment of differentiated thyroid carcinoma and analysis of recurrence-related factors].
    Chen FJ; Li QL; Zeng ZY; Song M; Yang AK; Zhang Q
    Ai Zheng; 2004 Nov; 23(11):1311-6. PubMed ID: 15522180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of residual occult malignancy in thyroid carcinoma.
    Turanli S; Aslan S; Cetin A
    Am J Otolaryngol; 2011; 32(5):398-401. PubMed ID: 21041002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is the timing of completion thyroidectomy for differentiated thyroid carcinoma prognostic significant?].
    Walgenbach S; Junginger T
    Zentralbl Chir; 2002 May; 127(5):435-8. PubMed ID: 12058304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reoperative thyroid surgery.
    Levin KE; Clark AH; Duh QY; Demeure M; Siperstein AE; Clark OH
    Surgery; 1992 Jun; 111(6):604-9. PubMed ID: 1595056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.